October 01, 2024
A Louisiana federal court has issued a sweeping loss to Big Pharma's top lobbying group and two pharmaceutical companies that argued a state law improperly expands the scope of the federal drug discount program.
April 08, 2024
Drugmaker AbbVie is asking a Louisiana federal judge to grant its summary judgment motion and block new state-level pharmaceutical caps for the federal 340B drug discount program, calling the state's competing summary judgment motion arguments "legally and factually wrong."
September 21, 2023
Drugmaker AbbVie Inc. hit Louisiana with a suit Thursday over requirements the state added to the controversial federal drug discount program, following another recent challenge to a law limiting Big Pharma's attempts to rein in pharmacy deals that have led to more discounted prices.